The effect of C1 inhibitor on myocardial ischemia and reperfusion injury
Authors:
- 1 January 2013
- journal article
- Published by Elsevier in Cardiovascular Pathology
- Vol. 22 (1) , 75-80
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health
This publication has 53 references indexed in Scilit:
- Humanized cobra venom factor decreases myocardial ischemia–reperfusion injuryMolecular Immunology, 2009
- Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind studyEuropean Journal of Cardio-Thoracic Surgery, 2007
- A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in ratsKidney International, 2003
- Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarctionEuropean Heart Journal, 2002
- C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical applicationMolecular Immunology, 1999
- P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin.Journal of Cell Biology, 1995
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardiumClinical and Experimental Immunology, 1990
- The role of the neutrophil and free radicals in ischemic myocardial injuryJournal of Molecular and Cellular Cardiology, 1989
- THE PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATSJournal of Experimental Medicine, 1971